Global Age Related Macular Degeneration (AMD) Market Growth (Status and Outlook) 2023-2029

Global Age Related Macular Degeneration (AMD) Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Age Related Macular Degeneration (AMD) Industry Forecast” looks at past sales and reviews total world Age Related Macular Degeneration (AMD) sales in 2022, providing a comprehensive analysis by region and market sector of projected Age Related Macular Degeneration (AMD) sales for 2023 through 2029. With Age Related Macular Degeneration (AMD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Age Related Macular Degeneration (AMD) industry.

This Insight Report provides a comprehensive analysis of the global Age Related Macular Degeneration (AMD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Age Related Macular Degeneration (AMD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Age Related Macular Degeneration (AMD) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Age Related Macular Degeneration (AMD) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Age Related Macular Degeneration (AMD).

The global Age Related Macular Degeneration (AMD) market size is projected to grow from US$ 1282.4 million in 2022 to US$ 1790.4 million in 2029; it is expected to grow at a CAGR of 4.9% from 2023 to 2029.

Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.

This report presents a comprehensive overview, market shares, and growth opportunities of Age Related Macular Degeneration (AMD) market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Wet AMD
Dry AMD

Segmentation by application
Men
Woman

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer

Please note: The report will take approximately 2 business days to prepare and deliver.